5.3. Analysis.

Comparison 5 Withdrawals at 54 weeks (infliximab/MTX versus Placebo/MTX), Outcome 3 Withdrawals Due to Lack Of Efficacy.

Comparison 5 Withdrawals at 54 weeks (infliximab/MTX versus Placebo/MTX), Outcome 3 Withdrawals Due to Lack Of Efficacy.